2024 annual financial data
Lyell Immunopharma 2024 Financial results
Direct answer
Revenue was 61,000 USD.
Operating income was -358.76M USD and net income was -342.99M USD.
Operating cash flow was -162.39M USD.
Get free Lyell Immunopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 61,000 USD
- Operating income
- -358.76M USD
- Net income
- -342.99M USD
- Operating cash flow
- -162.39M USD
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Lyell Immunopharma financial years